Fabian Theis says experimental follow-up may be easier to secure for molecule-related predictions, where the stakes are lower, than for interventions such as creating a new cell line or adding unusual substances.

“To actually buy into and then actually measure some of these follow-ups. And sometimes, you know, this works a bit better if it's sort of molecules because then, you know, so the stakes are not as high. But, you know, if you like say, you know, you need to do this new cell line, you need to add these very strange things.”